Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1993-10-28
2000-05-23
Davenport, Avis M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 15, 514 16, A61K 3800
Patent
active
060666226
ABSTRACT:
This invention provides methods of modulating the immune system by administering peptides of the formula R'-Glx-Glx-Lys-R" (SEQ ID NO:1) in which Glx is Glu or Gln. In particular, this invention provides the use of peptides Thr-Ala-Glu-Glu-Lys (SEQ ID NO:34) and Thr-Pro-Glu-Glu-Lys (SEQ ID NO:33).
REFERENCES:
patent: 4002602 (1977-01-01), Goldstein
patent: 4010148 (1977-03-01), Goldstein
patent: 4077949 (1978-03-01), Goldstein
patent: 4079127 (1978-03-01), Goldstein et al.
patent: 4116951 (1978-09-01), Wang
patent: 4120951 (1978-10-01), Goldstein
patent: 4133804 (1979-01-01), Bach et al.
patent: 4148788 (1979-04-01), Wang
patent: 4167557 (1979-09-01), Goldstein
patent: 4261886 (1981-04-01), Goldstein et al.
patent: 4264571 (1981-04-01), Goldstein et al.
patent: 4297276 (1981-10-01), Goldstein et al.
patent: 4339427 (1982-07-01), Goldstein et al.
patent: 4353821 (1982-10-01), Birr et al.
patent: 4374828 (1983-02-01), Folkers et. al.
patent: 4377511 (1983-03-01), Lopukhin et al.
patent: 4388234 (1983-06-01), Horecker
patent: 4389343 (1983-06-01), Horecker
patent: 4395404 (1983-07-01), Low et al.
patent: 4396605 (1983-08-01), Birr
patent: 4426324 (1984-01-01), Meienhofer
patent: 4427783 (1984-01-01), Newman et al.
patent: 4428938 (1984-01-01), Kisfaludy et al.
patent: 4442031 (1984-04-01), Felix et al.
patent: 4466918 (1984-08-01), Birr et al.
patent: 4470926 (1984-09-01), Birr et al.
patent: 4500450 (1985-02-01), Seipke et al.
patent: 4505853 (1985-03-01), Goldstein et al.
patent: 4517119 (1985-05-01), Felix et al.
patent: 4526717 (1985-07-01), Seipke et al.
patent: 4571336 (1986-02-01), Houck et al.
patent: 4599231 (1986-07-01), Milich et al.
patent: 4612365 (1986-09-01), Birr et al.
patent: 4614731 (1986-09-01), Horecker
patent: 4621135 (1986-11-01), Trainin et al.
patent: 4634682 (1987-01-01), Erickson et al.
patent: 4659694 (1987-04-01), Horecker
patent: 4696915 (1987-09-01), Horecker
patent: 4699898 (1987-10-01), Gottlieb
patent: 4711952 (1987-12-01), Kasafirek et al.
patent: 4722999 (1988-02-01), Handschumacher et al.
patent: 4751216 (1988-06-01), Gottlieb
patent: 4814434 (1989-03-01), Goldfarb
patent: 4826680 (1989-05-01), Jaeger
patent: 4904643 (1990-02-01), Brunetti et al.
patent: 4910296 (1990-03-01), Birr et al.
patent: 4983387 (1991-01-01), Goldstein et al.
patent: 7415283 (1988-12-01), Yakovlev et al.
CA 78: 43980, 1973, Bennett et al. R.S.Chen, CA 111: 55230r, 1989.
Hirschmann et al., CA 79:66820e, 1973.
Giori et al., CA 89: 215752v, 1978.
Cola et al., CA 111: 129603p, 1989.
Anisimov et al. (1982) Mechanisms of Ageing and Development, 19:245-258.
Anisimov et al. (1989) Mechanisms of Ageing and Development, 49:245-257.
Belokrylov et al. (1978) Bulletin of Experimental Biology, No. 7, 84:56-58.
Bespaluv et al. (1989) Eksp. Onkol., Chemical Abstracts III, Abstract No. 146389R, 11(4) 23-6 (Russ).
Cytomedins (Bulletin), Apr. 13, 1990, Russia.
Gavrilenko et al. (1982) Bulletin of Experimental Biology, No. 4, 93:39-40.
Goldstein et al. (1972) Proc. Natl. Acad. Sci. USA, 69:1800-1803.
R. S. Chen (1989) Chemical Abstracts, Vol. 111(7), Abstract No. 55230R.
Fauszt et al. (1975) Chemical Abstracts, Vol. 82(11), Abstract No. 73453C.
Khmel'nitskii et al. (1983), Bulletin of Experimental Biology, No. 6, 95:123-124.
Kuznik et al. (1982), Bulletin of Experimental Biology, No. 9, 94:27-29.
Kusnik et al. (1981) Bulletin of Experimental Biology, No. 9, 92:264-266.
Low et al. (1981) Proceedings of the National Academy of Science, 78:1162-1166.
Rodionov et al. (1990) "The Immunocorrective Therapy of Pyoderma Caused by Staphylococci Multiply Resistant to Antibiotics", Vestn. Dermatol. Venerol, 1:42-45 (Medline Abstract No. 90224329).
Solov'ev et al. (1977) Bulletin of Experimental Biology, No. 9, 84:355-358.
Solov'ev et al. (1983) Bulletin of Experimental Biology, No. 6, 95:123-124.
"Thymogen"(Bulletin ), Nov. 11, 1989, published by Cytomed (Leningrad).
Yakovlev et al., (1990) Resistance Stress Regulation, Nauka Publishers (Leningrad), pp. 90-93, 174-205.
Two brochures in Russian (no English translation).
Remington's. Pharmaceutical Science, 17th ed., Mack Publishing Co., Easton, PA (1985).
Stewart and Young, Solid Phase Peptide synthesis, 2nd ed., Pierce Chemical Company (1984).
Maniatis et al., (1982) Molecular Cloning, A Laboratory Manual, Cold Spring Harbor Laboratory.
Tam et al. (1983) J. Am. Chem. Soc., 105:6442.
Declaration of Lawrence R. Green.
Green Lawrence R.
Ivanov Vadim T.
Khavinson Vladimir K.
Mikhaltsov Alexander N.
Mikhalyova Inessa I.
Cytran, Inc.
Davenport Avis M.
LandOfFree
Immunomodulating peptides and methods of use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunomodulating peptides and methods of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunomodulating peptides and methods of use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1837158